{"symbol":"PFE","fiscalQuarter":"Q2-2016","reportDate":"2016-08-02","reportTime":"BMO","status":"reported","company":{"name":"Pfizer Inc.","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/PFE/earnings/Q2-2016","postBrief":{"headline":"Pfizer Beats on EPS, Stock Down 2.47%","keyNumbers":[{"metric":"EPS","actual":"$0.64","expected":"N/A","surprise":"+2.56%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management highlighted ongoing challenges in the market.","They emphasized the importance of strategic investments moving forward."],"summary":"Overall, management conveyed a cautious outlook amid market uncertainties. They stressed the need for continued focus on innovation."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Pfizer's earnings report showed a slight beat on EPS, which indicates some positive performance despite broader challenges. However, the stock fell by 2.47%, likely reflecting investor concerns about the lack of revenue data and the overall market environment. The cautious tone from management suggests that investors should remain vigilant about future performance.","metaDescription":"Pfizer (PFE) Q2 2016 earnings: EPS beat by 2.56%. Stock down 2.47%. Full breakdown."}}